Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pe...
Q1 2026
May 14, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 14, 2025